BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 33597325)

  • 1. Serum High-Sensitivity C-Reactive Protein Levels and the Development of Atrial Fibrillation in a General Japanese Population - The Hisayama Study.
    Yoshikawa T; Hata J; Sakata S; Nagata T; Hirakawa Y; Hirooka Y; Tsutsui H; Kitazono T; Ninomiya T
    Circ J; 2021 Jul; 85(8):1365-1372. PubMed ID: 33597325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Angiopoietin-Like Protein 2 Is a Novel Risk Factor for Cardiovascular Disease in the Community: The Hisayama Study.
    Hata J; Mukai N; Nagata M; Ohara T; Yoshida D; Kishimoto H; Shibata M; Hirakawa Y; Endo M; Ago T; Kitazono T; Oike Y; Kiyohara Y; Ninomiya T
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1686-91. PubMed ID: 27365403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum High-Sensitivity C-Reactive Protein Levels and the Risk of Atrial Fibrillation in Japanese Population: the Circulatory Risk in Communities Study.
    Tanaka M; Imano H; Kubota Y; Yamagishi K; Umesawa M; Muraki I; Cui R; Hayama-Terada M; Shimizu Y; Okada T; Ohira T; Sankai T; Tanigawa T; Sato S; Kitamura A; Kiyama M; Iso H;
    J Atheroscler Thromb; 2021 Feb; 28(2):194-202. PubMed ID: 32522907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome, high-sensitivity C-reactive protein levels and the risk of new-onset atrial fibrillation: Results from the Kailuan Study.
    Wang Z; Wang B; Li X; Zhang S; Wu S; Xia Y
    Nutr Metab Cardiovasc Dis; 2021 Jan; 31(1):102-109. PubMed ID: 33500102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive association between high-sensitivity C-reactive protein and incidence of type 2 diabetes mellitus in Japanese workers: 6-year follow-up.
    Wang C; Yatsuya H; Tamakoshi K; Uemura M; Li Y; Wada K; Yamashita K; Kawaguchi L; Toyoshima H; Aoyama A
    Diabetes Metab Res Rev; 2013 Jul; 29(5):398-405. PubMed ID: 23463453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Day-to-day home blood pressure variability and risk of atrial fibrillation in a general Japanese population: the Hisayama Study.
    Maezono A; Sakata S; Hata J; Oishi E; Furuta Y; Shibata M; Ide T; Kitazono T; Tsutsui H; Ninomiya T
    Eur J Prev Cardiol; 2024 Jan; ():. PubMed ID: 38284740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion.
    Watanabe E; Arakawa T; Uchiyama T; Kodama I; Hishida H
    Int J Cardiol; 2006 Apr; 108(3):346-53. PubMed ID: 15964643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Sensitivity C-Reactive Protein and Risk of Stroke in Atrial Fibrillation (from the Reasons for Geographic and Racial Differences in Stroke Study).
    Dawood FZ; Judd S; Howard VJ; Limdi NA; Meschia JF; Cushman M; Howard G; Herrington DM; Soliman EZ
    Am J Cardiol; 2016 Dec; 118(12):1826-1830. PubMed ID: 27712649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory biomarkers as risk factors for future atrial fibrillation. An eleven-year follow-up of 6315 men and women: the Tromsø study.
    Nyrnes A; Njølstad I; Mathiesen EB; Wilsgaard T; Hansen JB; Skjelbakken T; Jørgensen L; Løchen ML
    Gend Med; 2012 Dec; 9(6):536-547.e2. PubMed ID: 23046763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of C-reactive protein to the first onset and the recurrence rate in lone atrial fibrillation.
    Hatzinikolaou-Kotsakou E; Tziakas D; Hotidis A; Stakos D; Floros D; Papanas N; Chalikias G; Maltezos E; Hatseras DI
    Am J Cardiol; 2006 Mar; 97(5):659-61. PubMed ID: 16490433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematocrit and the risk of cardiovascular disease in a Japanese community: The Hisayama Study.
    Gotoh S; Hata J; Ninomiya T; Hirakawa Y; Nagata M; Mukai N; Fukuhara M; Ikeda F; Ago T; Kitazono T; Kiyohara Y
    Atherosclerosis; 2015 Sep; 242(1):199-204. PubMed ID: 26204496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between ratio of serum eicosapentaenoic acid to arachidonic acid and risk of cardiovascular disease: the Hisayama Study.
    Ninomiya T; Nagata M; Hata J; Hirakawa Y; Ozawa M; Yoshida D; Ohara T; Kishimoto H; Mukai N; Fukuhara M; Kitazono T; Kiyohara Y
    Atherosclerosis; 2013 Dec; 231(2):261-7. PubMed ID: 24267237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum uric acid levels and cardiovascular mortality in a general Japanese population: the Hisayama Study.
    Sakata S; Hata J; Honda T; Hirakawa Y; Oishi E; Shibata M; Yoshida D; Goto K; Kitazono T; Ninomiya T
    Hypertens Res; 2020 Jun; 43(6):560-568. PubMed ID: 31953527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Prediction Model for Incident Atrial Fibrillation in a General Japanese Population - The Hisayama Study.
    Hata J; Nagata T; Sakata S; Oishi E; Furuta Y; Hirakawa Y; Honda T; Yoshida D; Kitazono T; Ninomiya T
    Circ J; 2021 Jul; 85(8):1373-1382. PubMed ID: 33627542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between γ-glutamyltransferase level and incidence of atrial fibrillation: A nationwide population-based study.
    Lee SR; Choi EK; Han KD; Cha MJ; Oh S
    Int J Cardiol; 2017 Oct; 245():149-155. PubMed ID: 28757090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein and risk of atrial fibrillation in East Asians.
    Kwon CH; Kang JG; Lee HJ; Kim NH; Sung JW; Cheong E; Sung KC
    Europace; 2017 Oct; 19(10):1643-1649. PubMed ID: 27915263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion.
    Loricchio ML; Cianfrocca C; Pasceri V; Bianconi L; Auriti A; Calo L; Lamberti F; Castro A; Pandozi C; Palamara A; Santini M
    Am J Cardiol; 2007 May; 99(10):1421-4. PubMed ID: 17493472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cohort Study of Repeated Measurements of Serum Urate and Risk of Incident Atrial Fibrillation.
    Li S; Cheng J; Cui L; Gurol ME; Bhatt DL; Fonarow GC; Benjamin EJ; Xing A; Xia Y; Wu S; Gao X
    J Am Heart Assoc; 2019 Jul; 8(13):e012020. PubMed ID: 31213103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single and persistent elevation of C-reactive protein levels and the risk of atrial fibrillation in a general population: The Ansan-Ansung Cohort of the Korean Genome and Epidemiology Study.
    Lee Y; Park HC; Shin JH; Lim YH; Shin J; Park JK
    Int J Cardiol; 2019 Feb; 277():240-246. PubMed ID: 30409736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluctuating renal function and the risk of incident atrial fibrillation: a nationwide population-based study.
    Kwon S; Lee SR; Choi EK; Han KD; Yang S; Lee SY; Lee HJ; Moon I; Lee E; Cha MJ; Lim WH; Oh S; Lip GYH
    Sci Rep; 2019 Dec; 9(1):18055. PubMed ID: 31792292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.